Navigation Links
Former Patent Office Solicitor and Judge Joins Rothwell Figg
Date:1/10/2008

Nancy Linck Extends Firm's Life Sciences Capabilities

WASHINGTON, Jan. 10 /PRNewswire/ -- Rothwell, Figg, Ernst & Manbeck, P.C. announced today that Dr. Nancy J. Linck will join the firm in an Of Counsel position, effective Feb. 4, 2008. Dr. Linck has served as the former Solicitor and later an Administrative Patent Judge at the U.S. Patent & Trademark Office (USPTO), former Deputy General Counsel, IP & Trade, for the Biotechnology Industry Organization (BIO), and Senior Vice President, Intellectual Property and Regulatory Affairs and Chief Compliance Counsel, for Guilford Pharmaceuticals.

Dr. Linck commented that, "Rothwell, Figg, Ernst & Manbeck will provide an exceptional environment for me to return to private practice, and I am delighted to join what I have long regarded as one of the nation's leading intellectual property law firms."

"Rothwell Figg has, over many years, developed a strong biotechnology and pharmaceutical practice, and Nancy's extensive intellectual property expertise in these fields will help us expand our reach and continue to offer excellent service to our clients in these industries," Tony Figg of Rothwell, Figg, Ernst & Manbeck, P.C. said. "Nancy is one of the country's top IP lawyers, and her experience in private and corporate practice, as a frequent advocate for the USPTO in the Federal Circuit, and as a member of the Board of Patent Appeals and Interferences puts her in an extraordinary position to represent and counsel clients in a wide range of capacities."

The addition of Dr. Linck to the Rothwell Figg team is particularly timely in light of upcoming changes in the pharmaceutical and biotechnology markets. An estimated $29 billion worth of pharmaceutical patents are set to expire in the next two years, which will likely result in an increase in patent disputes as companies attempt to protect or extend their patents. Rothwell Figg will be well-positioned to advise companies on these matters.

Before becoming Solicitor at the USPTO, Nancy was a partner at Cushman, Darby & Cushman. In addition, Dr. Linck has corporate experience working both as a patent attorney for Monsanto and a chemist at Dow Chemical Company.

Other legal experience includes training as a mediator in the Federal Circuit's Pilot Mediation Program, serving as a consultant and expert witness in numerous patent cases in federal courts and in the FTC, and teaching law at both the Georgetown University Law Center and George Washington University School of Law.

Dr. Linck received her J.D. from Western New England College School of Law and her Ph.D. and M.S. in Inorganic Chemistry from the University of California, San Diego. She also holds a B.S. in Chemistry from the University of California, Berkeley, and expects to receive an M.S. in Biotechnology from Johns Hopkins University later this year.

Her bar membership includes the U.S. Supreme Court, U.S. Court of Appeals for the Federal Circuit, District of Columbia, U.S. Patent and Trademark Office, and Commonwealth of Massachusetts.

About Rothwell, Figg, Ernst & Manbeck, P.C.

Based in Washington, D.C., Rothwell Figg is one of the nation's top intellectual property law firms. The firm specializes in litigation, counseling, copyright, licensing and transactions, patent prosecution, trade dress, trademarks, and unfair competition. In addition to its patent and trademark prosecution, licensing and intellectual property counseling practices, the firm has handled a large number of complex and high-profile patent litigations before U.S. federal district courts and courts of appeals and the U.S. International Trade Commission, interference actions before the U.S. Patent and Trademark Office, and has argued patent appeals before the U.S. Patent and Trademark Office.


'/>"/>
SOURCE Rothwell, Figg, Ernst & Manbeck, P.C.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Vermillion (Formerly Ciphergen) Announces $20.5 Million Private Placement of Common Stock
2. Former Banc of America Securities Analyst David Maris Comments on Decision by Biovail to Drop Its Claims Against Him; Denies That He is Cooperating With Biovail
3. David Barker, Former Illumina CSO, Joins GenVaults Scientific Advisory Board
4. Former Pfizer Director of Inflammation Molecular Sciences to Spearhead Velcura Therapeutics Inflammatory Disease Initiatives
5. Kendle Appoints Former MHRA Head of Biologics as Principal Regulatory Affairs Consultant
6. Seahorse Bioscience Appoints Former Molecular Devices Executive Dr. Joseph D. Keegan to Board of Directors
7. Dynavax Issued Landmark Patent Covering Second-Generation TLR9 Agonists
8. VisEn Medical Files Action to Invalidate New Caliper Life Sciences Patent
9. Pressure BioSciences, Inc. Issued First Patent in Canada
10. Oncolytics Biotech Inc. Announces Issuance of 23rd U.S. Patent
11. CODA Genomics Announces Issuance of Optimized Synthetic Gene Production Patent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016  Blueprint Bio, a ... discoveries to the medical community, has closed its Series ... Matthew Nunez . "We have received a ... the capital we need to meet our current goals," ... provide us the runway to complete validation on the ...
(Date:6/23/2016)... 2016 On Wednesday, June 22, 2016, ... 0.22%; the Dow Jones Industrial Average edged 0.27% lower to ... down 0.17%. Stock-Callers.com has initiated coverage on the following equities: ... (NASDAQ: NKTR ), Aralez Pharmaceuticals Inc. (NASDAQ: ... BIND ). Learn more about these stocks by accessing their ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... and technical consulting, provides a free webinar on Performing Quality Investigations: ... 2016 at 12pm CT at no charge. , Incomplete investigations are still a ...
(Date:6/23/2016)... 2016  Amgen (NASDAQ: AMGN ) today ... life sciences incubator to accelerate the development of ... space at QB3@953 was created to help high-potential life ... many early stage organizations - access to laboratory infrastructure. ... launched two "Amgen Golden Ticket" awards, providing each winner ...
Breaking Biology Technology:
(Date:4/26/2016)... , April 27, 2016 ... "Global Multi-modal Biometrics Market 2016-2020"  report to their ... , The analysts forecast the global ... of 15.49% during the period 2016-2020.  ... of sectors such as the healthcare, BFSI, transportation, ...
(Date:4/15/2016)... 2016  A new partnership announced today will ... decisions in a fraction of the time it ... high-value life insurance policies to consumers without requiring ... Force Diagnostics, rapid testing (A1C, Cotinine and HIV) ... pressure, weight, pulse, BMI, and activity data) available ...
(Date:4/14/2016)... , April 14, 2016 ... and Malware Detection, today announced the appointment of ... the new role. Goldwerger,s leadership appointment comes ... the heels of the deployment of its platform at ... behavioral biometric technology, which discerns unique cognitive and physiological ...
Breaking Biology News(10 mins):